CN Patent

CN101703481B — 一种利巴韦林脂微球泡腾颗粒

Assigned to Hainan Lingkang Pharmaceutical Co Ltd · Expires 2010-12-29 · 15y expired

What this patent protects

本发明涉及一种靶向给药系统的利巴韦林脂微球及其制法，特别涉及一种利巴韦林脂微球泡腾颗粒及其制法。本发明通过将一定含量的蛋黄卵磷脂、胆固醇、去氧胆酸钠和活性成分利巴韦林进行组合，采用薄膜分散技术制成利巴韦林脂微球，然后再和一定的辅料混合制成泡腾颗粒，起效迅速，生物利用度高，毒副作用小，从而获得了令人满意的技术效果。

USPTO Abstract

本发明涉及一种靶向给药系统的利巴韦林脂微球及其制法，特别涉及一种利巴韦林脂微球泡腾颗粒及其制法。本发明通过将一定含量的蛋黄卵磷脂、胆固醇、去氧胆酸钠和活性成分利巴韦林进行组合，采用薄膜分散技术制成利巴韦林脂微球，然后再和一定的辅料混合制成泡腾颗粒，起效迅速，生物利用度高，毒副作用小，从而获得了令人满意的技术效果。

Drugs covered by this patent

Patent Metadata

Patent number
CN101703481B
Jurisdiction
CN
Classification
—
Expires
2010-12-29
Drug substance claim
No
Drug product claim
No
Assignee
Hainan Lingkang Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.